NPY5R and lung carcinoma: We found that brain metastatic lesions of lung cancer exhibited significantly higher expression of the NPY5R (Y5R) compared to other NPY receptors, and the expression of Y5R was selectively enriched in metastatic lung cancer, in contrast to metastatic breast and melanoma cancer (Fig. 3A).